Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 29
2024
|
Jason Pitofsky VP Controller |
BUY
Bona fide gift
|
Indirect |
90
+33.46%
|
-
|
|
Apr 29
2024
|
George Yancopoulos Bd. Co-Chair, President & CSO |
BUY
Bona fide gift
|
Indirect |
18,148
+50.0%
|
-
|
|
Apr 29
2024
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Bona fide gift
|
Indirect |
36,296
-100.0%
|
-
|
|
Apr 04
2024
|
Jason Pitofsky VP Controller |
BUY
Bona fide gift
|
Indirect |
89
+50.0%
|
-
|
|
Apr 01
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
250
-1.86%
|
$241,000
$964.73 P/Share
|
|
Apr 01
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$96,100
$961.56 P/Share
|
|
Mar 14
2024
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
5,783
-0.8%
|
$5,540,114
$958.88 P/Share
|
|
Mar 13
2024
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
14,217
-20.81%
|
$13,804,707
$971.82 P/Share
|
|
Mar 13
2024
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+22.65%
|
$7,980,000
$399.66 P/Share
|
|
Mar 01
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
358
-2.6%
|
$346,186
$967.5 P/Share
|
|
Mar 01
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$97,800
$978.23 P/Share
|
|
Feb 26
2024
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
1,020
-1.96%
|
-
|
|
Feb 26
2024
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.86%
|
$992,000
$992.5 P/Share
|
|
Feb 26
2024
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.83%
|
$413,000
$413.33 P/Share
|
|
Feb 26
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
1,000
-2.66%
|
$990,000
$990.0 P/Share
|
|
Feb 26
2024
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
854
-38.19%
|
$836,066
$979.25 P/Share
|
|
Feb 26
2024
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
854
+27.64%
|
$333,914
$391.92 P/Share
|
|
Feb 23
2024
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
500
-1.86%
|
$492,500
$985.0 P/Share
|
|
Feb 23
2024
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.83%
|
$206,500
$413.33 P/Share
|
|
Feb 22
2024
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
3,000
-3.66%
|
$2,895,000
$965.0 P/Share
|
|
Feb 22
2024
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+3.53%
|
$1,239,000
$413.33 P/Share
|
|
Feb 22
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
1,000
-2.59%
|
$967,000
$967.65 P/Share
|
|
Feb 15
2024
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
123,601
-13.36%
|
$117,791,753
$953.83 P/Share
|
|
Feb 15
2024
|
George Yancopoulos Bd. Co-Chair, President & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
172,723
+15.73%
|
$68,916,477
$399.66 P/Share
|
|
Feb 14
2024
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Open market or private sale
|
Direct |
10,434
-3.03%
|
$9,849,696
$944.53 P/Share
|
|
Feb 09
2024
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
24,941
-30.51%
|
$23,718,891
$951.68 P/Share
|
|
Feb 09
2024
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Exercise of conversion of derivative security
|
Direct |
35,375
+30.1%
|
$13,301,000
$376.93 P/Share
|
|
Feb 09
2024
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
4,919
-4.76%
|
$4,682,888
$952.92 P/Share
|
|
Feb 09
2024
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
500
-1.86%
|
$477,500
$955.0 P/Share
|
|
Feb 09
2024
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.83%
|
$206,500
$413.33 P/Share
|
|
Feb 08
2024
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
500
-1.86%
|
$472,500
$945.0 P/Share
|
|
Feb 08
2024
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.83%
|
$206,500
$413.33 P/Share
|
|
Feb 07
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
1,000
-2.53%
|
$950,000
$950.0 P/Share
|
|
Feb 07
2024
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
8,037
-2.02%
|
$7,635,150
$950.41 P/Share
|
|
Feb 05
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-6.76%
|
$934,000
$934.71 P/Share
|
|
Feb 02
2024
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-1.17%
|
$268,636
$956.65 P/Share
|
|
Feb 02
2024
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.64%
|
$151,200
$378.98 P/Share
|
|
Feb 02
2024
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
22,713
-27.44%
|
$21,713,628
$956.65 P/Share
|
|
Feb 02
2024
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
30,750
+27.09%
|
$12,269,250
$399.66 P/Share
|
|
Feb 01
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$95,200
$952.51 P/Share
|
|
Feb 01
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
273
-1.81%
|
$257,985
$945.61 P/Share
|
|
Jan 31
2024
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-1.18%
|
$268,746
$953.42 P/Share
|
|
Jan 31
2024
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.65%
|
$151,200
$378.98 P/Share
|
|
Jan 30
2024
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
827
-37.44%
|
$793,093
$959.0 P/Share
|
|
Jan 30
2024
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
827
+27.24%
|
$314,260
$380.95 P/Share
|
|
Jan 24
2024
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
352
-1.48%
|
$334,752
$951.26 P/Share
|
|
Jan 24
2024
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.06%
|
$189,000
$378.98 P/Share
|
|
Jan 23
2024
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
776
-3.22%
|
$735,648
$948.5 P/Share
|
|
Jan 23
2024
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+4.37%
|
$415,800
$378.98 P/Share
|
|
Jan 23
2024
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,569
-16.95%
|
$7,175,412
$948.5 P/Share
|